z-logo
open-access-imgOpen Access
Tolvaptan Response in a Hyponatremic Newborn with Syndrome of Inappropriate Secretion of Antidiuretic Hormone
Author(s) -
Cengiz Zeybek,
Ali Dinç Bozat,
Erhan Çalışıcı,
Ahmet Bolat,
Belma Saygılı Karagöl
Publication year - 2021
Publication title -
case reports in pediatrics
Language(s) - English
Resource type - Journals
eISSN - 2090-6803
pISSN - 2090-6811
DOI - 10.1155/2021/9920817
Subject(s) - tolvaptan , medicine , hyponatremia , antidiuretic , syndrome of inappropriate antidiuretic hormone secretion , vasopressin , hormone , intensive care medicine , pediatrics
The use of tolvaptan to treat both euvolemic and hypervolemic hyponatremia has rapidly increased in recent years. However, data on its effects on children, especially newborns and infants, are limited. Here, we present a newborn who developed syndrome of inappropriate secretion of antidiuretic hormone following an intracranial hematoma drainage operation who was unresponsive to conventional treatments. The infant was successfully treated with tolvaptan, a competitive inhibitor of the vasopressin V2 receptor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom